Cargando…

Integration of Placental Transfer in a Fetal–Maternal Physiologically Based Pharmacokinetic Model to Characterize Acetaminophen Exposure and Metabolic Clearance in the Fetus

BACKGROUND AND OBJECTIVE: Although acetaminophen is frequently used during pregnancy, little is known about fetal acetaminophen pharmacokinetics. Acetaminophen safety evaluation has typically focused on hepatotoxicity, while other events (fetal ductal closure/constriction) are also relevant. We aime...

Descripción completa

Detalles Bibliográficos
Autores principales: Mian, Paola, Allegaert, Karel, Conings, Sigrid, Annaert, Pieter, Tibboel, Dick, Pfister, Marc, van Calsteren, Kristel, van den Anker, John N., Dallmann, André
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329787/
https://www.ncbi.nlm.nih.gov/pubmed/32052378
http://dx.doi.org/10.1007/s40262-020-00861-7
_version_ 1783552969379151872
author Mian, Paola
Allegaert, Karel
Conings, Sigrid
Annaert, Pieter
Tibboel, Dick
Pfister, Marc
van Calsteren, Kristel
van den Anker, John N.
Dallmann, André
author_facet Mian, Paola
Allegaert, Karel
Conings, Sigrid
Annaert, Pieter
Tibboel, Dick
Pfister, Marc
van Calsteren, Kristel
van den Anker, John N.
Dallmann, André
author_sort Mian, Paola
collection PubMed
description BACKGROUND AND OBJECTIVE: Although acetaminophen is frequently used during pregnancy, little is known about fetal acetaminophen pharmacokinetics. Acetaminophen safety evaluation has typically focused on hepatotoxicity, while other events (fetal ductal closure/constriction) are also relevant. We aimed to develop a fetal–maternal physiologically based pharmacokinetic (PBPK) model (f-m PBPK) to quantitatively predict placental acetaminophen transfer, characterize fetal acetaminophen exposure, and quantify the contributions of specific clearance pathways in the term fetus. METHODS: An acetaminophen pregnancy PBPK model was extended with a compartment representing the fetal liver, which included maturation of relevant enzymes. Different approaches to describe placental transfer were evaluated (ex vivo cotyledon perfusion experiments, placental transfer prediction based on Caco-2 cell permeability or physicochemical properties [MoBi(®)]). Predicted maternal and fetal acetaminophen profiles were compared with in vivo observations. RESULTS: Tested approaches to predict placental transfer showed comparable performance, although the ex vivo approach showed highest prediction accuracy. Acetaminophen exposure in maternal venous blood was similar to fetal venous umbilical cord blood. Prediction of fetal acetaminophen clearance indicated that the median molar dose fraction converted to acetaminophen-sulphate and N-acetyl-p-benzoquinone imine was 0.8% and 0.06%, respectively. The predicted mean acetaminophen concentration in the arterial umbilical cord blood was 3.6 mg/L. CONCLUSION: The median dose fraction of acetaminophen converted to its metabolites in the term fetus was predicted. The various placental transfer approaches supported the development of a generic f-m PBPK model incorporating in vivo placental drug transfer. The predicted arterial umbilical cord acetaminophen concentration was far below the suggested postnatal threshold (24.47 mg/L) for ductal closure. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s40262-020-00861-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7329787
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-73297872020-07-07 Integration of Placental Transfer in a Fetal–Maternal Physiologically Based Pharmacokinetic Model to Characterize Acetaminophen Exposure and Metabolic Clearance in the Fetus Mian, Paola Allegaert, Karel Conings, Sigrid Annaert, Pieter Tibboel, Dick Pfister, Marc van Calsteren, Kristel van den Anker, John N. Dallmann, André Clin Pharmacokinet Original Research Article BACKGROUND AND OBJECTIVE: Although acetaminophen is frequently used during pregnancy, little is known about fetal acetaminophen pharmacokinetics. Acetaminophen safety evaluation has typically focused on hepatotoxicity, while other events (fetal ductal closure/constriction) are also relevant. We aimed to develop a fetal–maternal physiologically based pharmacokinetic (PBPK) model (f-m PBPK) to quantitatively predict placental acetaminophen transfer, characterize fetal acetaminophen exposure, and quantify the contributions of specific clearance pathways in the term fetus. METHODS: An acetaminophen pregnancy PBPK model was extended with a compartment representing the fetal liver, which included maturation of relevant enzymes. Different approaches to describe placental transfer were evaluated (ex vivo cotyledon perfusion experiments, placental transfer prediction based on Caco-2 cell permeability or physicochemical properties [MoBi(®)]). Predicted maternal and fetal acetaminophen profiles were compared with in vivo observations. RESULTS: Tested approaches to predict placental transfer showed comparable performance, although the ex vivo approach showed highest prediction accuracy. Acetaminophen exposure in maternal venous blood was similar to fetal venous umbilical cord blood. Prediction of fetal acetaminophen clearance indicated that the median molar dose fraction converted to acetaminophen-sulphate and N-acetyl-p-benzoquinone imine was 0.8% and 0.06%, respectively. The predicted mean acetaminophen concentration in the arterial umbilical cord blood was 3.6 mg/L. CONCLUSION: The median dose fraction of acetaminophen converted to its metabolites in the term fetus was predicted. The various placental transfer approaches supported the development of a generic f-m PBPK model incorporating in vivo placental drug transfer. The predicted arterial umbilical cord acetaminophen concentration was far below the suggested postnatal threshold (24.47 mg/L) for ductal closure. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s40262-020-00861-7) contains supplementary material, which is available to authorized users. Springer International Publishing 2020-02-12 2020 /pmc/articles/PMC7329787/ /pubmed/32052378 http://dx.doi.org/10.1007/s40262-020-00861-7 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holdestimates of the fitted exer.To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Original Research Article
Mian, Paola
Allegaert, Karel
Conings, Sigrid
Annaert, Pieter
Tibboel, Dick
Pfister, Marc
van Calsteren, Kristel
van den Anker, John N.
Dallmann, André
Integration of Placental Transfer in a Fetal–Maternal Physiologically Based Pharmacokinetic Model to Characterize Acetaminophen Exposure and Metabolic Clearance in the Fetus
title Integration of Placental Transfer in a Fetal–Maternal Physiologically Based Pharmacokinetic Model to Characterize Acetaminophen Exposure and Metabolic Clearance in the Fetus
title_full Integration of Placental Transfer in a Fetal–Maternal Physiologically Based Pharmacokinetic Model to Characterize Acetaminophen Exposure and Metabolic Clearance in the Fetus
title_fullStr Integration of Placental Transfer in a Fetal–Maternal Physiologically Based Pharmacokinetic Model to Characterize Acetaminophen Exposure and Metabolic Clearance in the Fetus
title_full_unstemmed Integration of Placental Transfer in a Fetal–Maternal Physiologically Based Pharmacokinetic Model to Characterize Acetaminophen Exposure and Metabolic Clearance in the Fetus
title_short Integration of Placental Transfer in a Fetal–Maternal Physiologically Based Pharmacokinetic Model to Characterize Acetaminophen Exposure and Metabolic Clearance in the Fetus
title_sort integration of placental transfer in a fetal–maternal physiologically based pharmacokinetic model to characterize acetaminophen exposure and metabolic clearance in the fetus
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329787/
https://www.ncbi.nlm.nih.gov/pubmed/32052378
http://dx.doi.org/10.1007/s40262-020-00861-7
work_keys_str_mv AT mianpaola integrationofplacentaltransferinafetalmaternalphysiologicallybasedpharmacokineticmodeltocharacterizeacetaminophenexposureandmetabolicclearanceinthefetus
AT allegaertkarel integrationofplacentaltransferinafetalmaternalphysiologicallybasedpharmacokineticmodeltocharacterizeacetaminophenexposureandmetabolicclearanceinthefetus
AT coningssigrid integrationofplacentaltransferinafetalmaternalphysiologicallybasedpharmacokineticmodeltocharacterizeacetaminophenexposureandmetabolicclearanceinthefetus
AT annaertpieter integrationofplacentaltransferinafetalmaternalphysiologicallybasedpharmacokineticmodeltocharacterizeacetaminophenexposureandmetabolicclearanceinthefetus
AT tibboeldick integrationofplacentaltransferinafetalmaternalphysiologicallybasedpharmacokineticmodeltocharacterizeacetaminophenexposureandmetabolicclearanceinthefetus
AT pfistermarc integrationofplacentaltransferinafetalmaternalphysiologicallybasedpharmacokineticmodeltocharacterizeacetaminophenexposureandmetabolicclearanceinthefetus
AT vancalsterenkristel integrationofplacentaltransferinafetalmaternalphysiologicallybasedpharmacokineticmodeltocharacterizeacetaminophenexposureandmetabolicclearanceinthefetus
AT vandenankerjohnn integrationofplacentaltransferinafetalmaternalphysiologicallybasedpharmacokineticmodeltocharacterizeacetaminophenexposureandmetabolicclearanceinthefetus
AT dallmannandre integrationofplacentaltransferinafetalmaternalphysiologicallybasedpharmacokineticmodeltocharacterizeacetaminophenexposureandmetabolicclearanceinthefetus